To standardise DKA management processes by improving adherence to the JBDS-IP guidelines
Facilitates widening the project and conduct advanced analysis to look for regional best practices.
However, Sanofi does not provide input on the design or analysis, and they do not have access to raw data.
Studies have shown significant variation in DKA care between patients despite using the same guidelines. Traditional audits have fallen short in addressing this variation in patient care associated with DKA, which demands immediate attention. Building upon our successful endeavours in improving DKA management through a quality improvement project, we have pioneered an innovative solution – the Digital Evaluation of Ketosis and Other Diabetes Emergencies (DEKODE), which has a win-win-win strategy:
1. Win for you: You will save time spent designing an audit or analysing the data, which usually accounts for approximately 50% of the workload.
2. Win for the community: Aggregated data from participating hospitals offers insights into evolving DKA care trends, informing future guidelines and improving healthcare at a national level.
3. Win for patients: Reduced care variation improves patient outcomes, ensuring consistent and effective management.
2. Gain Approvals: Obtain necessary approvals from your local clinical governance or ethics committee to participate in the program.
3. Data Collection: Designate a qualified healthcare professional (medical student, junior doctor, or specialist nurse) to collect data on DKA cases and enter their pseudonymised data into the secure DEKODE form.
4. Feedback and Improvement: Benefit from regular feedback on your hospital's performance, gain insights into areas requiring improvement, and learn from successful interventions implemented by other participating hospitals.